GO:0120539 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0120539 describes the enzymatic decarboxylation of a 4-hydroxy-3-methoxy-5-(all-trans-polyprenyl)benzoate to a 2-methoxy-6-(all-trans-polyprenyl)phenol with release of CO2.
• The reaction is a key step in the biosynthesis of prenylated phenols, including ubiquinone (coenzyme Q) and related isoprenoid quinones.
• Decarboxylases are widely used in biocatalysis for asymmetric synthesis and production of fine chemicals.
• Enzyme activity depends on the polyprenyl chain length and substrate recognition, as shown for other decarboxylases.
• Dysregulation of decarboxylase-mediated pathways has been linked to sepsis and inflammatory responses.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of this activity in cells and organisms.
Description
GO:0120539, 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity, is a molecular function defined by the removal of a carboxyl group from a prenylated benzoate substrate to yield a prenylated phenol and carbon dioxide. This activity is part of the broader class of decarboxylases that catalyze the cleavage of carbon-carbon bonds adjacent to a carboxyl group, often with the aid of cofactors or metal ions. The reaction is chemically related to other decarboxylation processes that are central to primary and secondary metabolism, including those involved in ubiquinone biosynthesis and the production of aromatic compounds. Understanding this activity is important because prenylated phenols serve as electron carriers and antioxidants in respiratory chains, and their biosynthesis intersects with pathways that are targeted in antimicrobial and anticancer research. Moreover, decarboxylases are increasingly exploited as biocatalysts for asymmetric synthesis, making the mechanistic details of GO:0120539 relevant for enzyme engineering. The study of this activity also benefits from comparative analysis of other decarboxylases, such as sodium ion-translocating decarboxylases and pyridoxal 5'-phosphate-dependent enzymes, which provide structural and mechanistic frameworks.
4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity At A Glance
| GO ID | GO:0120539 |
|---|---|
| GO term | 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of the decarboxylation of a prenylated benzoate to a prenylated phenol and CO2 |
| Reaction | a 4-hydroxy-3-methoxy-5-(all-trans-polyprenyl)benzoate + H+ = a 2-methoxy-6-(all-trans-polyprenyl)phenol + CO2 |
| Enzyme class | Lyase (carbon-carbon lyase) |
| Substrate | 4-hydroxy-3-methoxy-5-(all-trans-polyprenyl)benzoate |
| Product | 2-methoxy-6-(all-trans-polyprenyl)phenol + CO2 |
What Is GO:0120539?
In simple terms, GO:0120539 describes an enzyme that removes a carboxyl group from a specific prenylated benzoate molecule, releasing carbon dioxide and leaving behind a prenylated phenol. The reaction is: a 4-hydroxy-3-methoxy-5-(all-trans-polyprenyl)benzoate + H+ = a 2-methoxy-6-(all-trans-polyprenyl)phenol + CO2. This activity is classified as a molecular function and is part of the lyase class of enzymes, specifically those acting on carbon-carbon bonds. The substrate contains a polyprenyl side chain that anchors the molecule in membranes, and the decarboxylation step is often a committed step in the biosynthesis of prenylated quinones.
Why Is 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity Important in Cell Biology?
GO:0120539 is important because it represents a committed step in the biosynthesis of prenylated phenols, which are essential for electron transport and antioxidant defense in many organisms. The activity is also a model for understanding decarboxylation chemistry, which is widely used in biocatalysis for the production of chiral intermediates and fine chemicals. Additionally, decarboxylases have been implicated in human disease, including sepsis, where dysregulated decarboxylase activity contributes to inflammatory responses. Studying this activity can inform the development of inhibitors or engineered enzymes for therapeutic and industrial applications.
• Provides a key step in ubiquinone and prenylated phenol biosynthesis.
• Represents a class of lyases that are valuable for asymmetric synthesis.
• Contributes to cellular redox balance and respiratory chain function.
• Serves as a target for understanding enzyme mechanism and substrate specificity.
• Linked to inflammatory diseases such as sepsis through related decarboxylases.
• Enables comparative studies with other decarboxylases, including sodium ion-translocating enzymes.
• Facilitates the development of CRISPR models to study gene function in vivo.
• Supports metabolic engineering for production of prenylated compounds.
• Helps elucidate the role of polyprenyl chain length in enzyme recognition.
• Offers a paradigm for studying cofactor-independent decarboxylation mechanisms.
Molecular Mechanism of 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity
Substrate Binding and Recognition
In simple terms: The enzyme first grabs the prenylated benzoate molecule in a way that positions the carboxyl group for removal.
The enzyme binds the 4-hydroxy-3-methoxy-5-(all-trans-polyprenyl)benzoate substrate through a combination of hydrophobic interactions with the polyprenyl chain and polar interactions with the benzoate headgroup. Structural studies of related decarboxylases, such as l-methionine decarboxylase, have revealed that substrate specificity is determined by the shape and chemical environment of the active site pocket. The polyprenyl chain likely anchors the substrate in the membrane or at the membrane interface, while the carboxyl group is oriented toward catalytic residues.
Catalytic Decarboxylation
In simple terms: Once bound, the enzyme breaks the bond between the carboxyl carbon and the aromatic ring, releasing carbon dioxide.
The decarboxylation step proceeds through a mechanism that may involve stabilization of a carbanion intermediate or a concerted process. Many decarboxylases use cofactors such as pyridoxal 5'-phosphate (PLP) or metal ions, but some, like the sodium ion-translocating decarboxylases, use a biotin-dependent mechanism. The reaction catalyzed by GO:0120539 is thought to be cofactor-independent, relying on active site residues to polarize the carboxyl group and facilitate CO2 release. The product, a 2-methoxy-6-(all-trans-polyprenyl)phenol, is a prenylated phenol that can undergo further modifications.
Product Release and Turnover
In simple terms: After the reaction, the enzyme lets go of the phenol product and carbon dioxide, ready to start again.
Following decarboxylation, the prenylated phenol product is released from the active site, and the enzyme returns to its resting state. The release step may be rate-limiting and can be influenced by membrane environment and substrate availability. Turnover efficiency is critical for metabolic flux through the prenylated phenol biosynthetic pathway, which supplies components for electron transport chains.
Cofactors and Cofactor-Independent Mechanisms
In simple terms: Unlike some decarboxylases that need helper molecules, this enzyme may work without them.
While many decarboxylases require PLP or metal ions, the reaction described by GO:0120539 appears to be cofactor-independent, similar to other aromatic decarboxylases. However, some decarboxylases exhibit oxygen reactivity with PLP, which can modulate activity. The absence of a cofactor simplifies the catalytic mechanism but may impose constraints on the range of substrates accepted.
Regulation of Enzyme Activity
In simple terms: The enzyme's activity can be turned up or down by cellular signals and metabolic needs.
The activity of 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase is likely regulated at the transcriptional level and by substrate availability. In related pathways, such as ubiquinone biosynthesis, expression is coordinated with respiratory demand. Post-translational modifications and membrane lipid composition may also influence enzyme function. Additionally, the enzyme may be subject to feedback inhibition by downstream products.
Key Genes Involved in GO:0120539 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity
The following genes and proteins are associated with decarboxylase activities and related pathways, providing context for studying GO:0120539.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ubiD | Decarboxylase in ubiquinone biosynthesis | Model for prenylated benzoate decarboxylation |
| ubiX | Decarboxylase in ubiquinone biosynthesis | Similar mechanism to GO:0120539 |
| COQ2 | Prenyltransferase in ubiquinone biosynthesis | Provides substrate for decarboxylase |
| COQ3 | O-methyltransferase | Modifies prenylated intermediates |
| COQ5 | Methyltransferase | Part of ubiquinone pathway |
| COQ6 | Monooxygenase | Hydroxylates prenylated benzoate |
| COQ7 | Hydroxylase | Final steps of ubiquinone synthesis |
| ACOD1 | Aconitate decarboxylase | Involved in sepsis and inflammation |
| LOG | Cytokinin-activating enzyme | Initially misannotated as lysine decarboxylase |
| LDC | Lysine decarboxylase | Model for substrate specificity |
| MDC | l-methionine decarboxylase | Structural insights into decarboxylation |
| PDX1 | Pyridoxal 5'-phosphate synthesis | Cofactor supply for PLP-dependent enzymes |
| PDX2 | Pyridoxal 5'-phosphate synthesis | Cofactor supply |
| GAD | Glutamate decarboxylase | Related PLP-dependent decarboxylase |
| HDC | Histidine decarboxylase | Related to microcirculation and histamine |
| ODC | Ornithine decarboxylase | Polyamine biosynthesis |
| ADC | Arginine decarboxylase | Polyamine biosynthesis |
How Is 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity Regulated?
The activity of 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase is likely regulated by substrate availability and transcriptional control of the biosynthetic operon. In ubiquinone biosynthesis, expression of decarboxylases is coordinated with respiratory chain demand and oxygen availability. Additionally, oxygen reactivity with PLP-dependent enzymes can modulate activity, although GO:0120539 appears to be cofactor-independent. Feedback inhibition by downstream prenylated phenols may also play a role.
4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ACOD1 | Sepsis and inflammation | Knockout mice, macrophage cell lines |
| COQ2 | Coenzyme Q10 deficiency | Patient fibroblasts, iPSC-derived neurons |
| COQ6 | Steroid-resistant nephrotic syndrome | Podocyte models |
| ODC | Cancer cell proliferation | Cancer cell lines, xenografts |
| HDC | Histamine-related microcirculation disorders | Endothelial cell models |
Inflammation and Sepsis
Dysregulated decarboxylase activity has been linked to inflammatory diseases. For example, aconitate decarboxylase 1 (ACOD1) mediates polymicrobial sepsis by producing itaconate, which modulates immune responses. Although GO:0120539 is distinct, the broader family of decarboxylases contributes to metabolic reprogramming in inflammation.
Metabolic Disorders
Defects in ubiquinone biosynthesis, which involves prenylated benzoate decarboxylation, can lead to mitochondrial dysfunction and metabolic disorders. Understanding GO:0120539 may help identify therapeutic targets for such conditions.
Cancer Metabolism
Decarboxylases are often upregulated in cancer to support anabolic growth. For instance, ornithine decarboxylase is a known oncogene. While GO:0120539 has not been directly linked to cancer, its role in prenylated phenol biosynthesis could influence redox balance in tumor cells.
From 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of the decarboxylase gene affect ubiquinone levels? | CRISPR knockout in HEK293 or HepG2 cells |
| What is the effect of a point mutation in the active site? | CRISPR point mutation knock-in in cell lines |
| Can the enzyme be tagged for localization studies? | Knock-in of FLAG or GFP tag |
| Does overexpression alter prenylated phenol production? | Overexpression in E. coli or mammalian cells |
| Which genes interact with the decarboxylase? | CRISPR library screening with a focused library |
| What is the metabolic impact of the decarboxylase in vivo? | Knockout mouse models |
How to Study the 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC-MS | Substrate and product levels | Enzyme kinetics and pathway flux |
| CO2 release assay | Decarboxylase activity | High-throughput screening |
| CRISPR knockout | Gene function | Loss-of-function studies |
| CRISPR point mutation | Specific residue function | Mechanistic studies |
| Knock-in tagging | Protein localization | Imaging and proteomics |
| Overexpression | Gain-of-function effects | Metabolic engineering |
| Metabolomics | Global metabolite changes | Pathway analysis |
| Structural biology | 3D structure | Enzyme design |
Enzymatic Assays
Direct measurement of decarboxylase activity can be performed using purified enzyme and substrate, monitoring CO2 release or product formation by HPLC or mass spectrometry. These assays are essential for kinetic characterization and inhibitor testing.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that modulate decarboxylase activity or compensate for its loss. Libraries targeting metabolic enzymes are particularly useful.
Metabolomics
Untargeted or targeted metabolomics can quantify prenylated benzoates and phenols, providing a readout of pathway flux. This approach is valuable for validating CRISPR models.
Structural Biology
X-ray crystallography or cryo-EM of the decarboxylase can reveal substrate binding and catalytic residues, as demonstrated for l-methionine decarboxylase. These studies guide enzyme engineering.
How CRISPR Can Be Used to Study GO:0120539 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity
Knockout
CRISPR knockout of the gene encoding the decarboxylase can abolish activity, allowing researchers to assess its role in prenylated phenol biosynthesis and cellular metabolism. Knockout cell lines are valuable for metabolic profiling and drug sensitivity tests.
Point Mutation
Introducing point mutations in catalytic residues via CRISPR can dissect the mechanism of decarboxylation. For example, mutating a putative active-site base can reveal its role in substrate activation.
Knock-in
Knock-in of epitope tags or fluorescent proteins enables visualization and affinity purification of the decarboxylase, facilitating interaction studies and localization analysis.
Overexpression
CRISPR activation or cDNA overexpression can increase decarboxylase levels, boosting flux through the pathway. This is useful for producing prenylated phenols in engineered cells.
How EDITGENE Supports 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity Research
Researchers studying 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated. EDITGENE provides a comprehensive suite of CRISPR services to enable such causal studies, from knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity research.
Frequently Asked Questions About 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity
What is GO:0120539?
GO:0120539 is the Gene Ontology term for 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity, a molecular function that catalyzes the removal of a carboxyl group from a prenylated benzoate to form a prenylated phenol and CO2.
What reaction does 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase catalyze?
It catalyzes the reaction: a 4-hydroxy-3-methoxy-5-(all-trans-polyprenyl)benzoate + H+ = a 2-methoxy-6-(all-trans-polyprenyl)phenol + CO2.
What genes are involved in 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity?
Genes such as ubiD and ubiX in bacteria, and COQ genes in eukaryotes, are involved in related decarboxylation steps in ubiquinone biosynthesis.
Is 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase a lyase?
Yes, it is classified as a carbon-carbon lyase because it breaks a carbon-carbon bond.
What diseases are associated with decarboxylase dysfunction?
Decarboxylase dysfunction has been linked to sepsis, metabolic disorders, and cancer, although specific links to GO:0120539 require further study.
How can I study 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity?
You can use enzymatic assays, CRISPR knockout, metabolomics, and structural biology to study this activity.
What model systems are used for decarboxylase research?
Common models include E. coli, yeast, and mammalian cell lines, as well as knockout mice.
Does 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase require a cofactor?
It appears to be cofactor-independent, unlike PLP-dependent decarboxylases.
What is the substrate specificity of this enzyme?
It specifically recognizes 4-hydroxy-3-methoxy-5-(all-trans-polyprenyl)benzoate, with the polyprenyl chain length influencing binding.
How does CRISPR help study this activity?
CRISPR enables knockout, point mutation, knock-in, and overexpression to causally link genes to the activity.
Conclusion
GO:0120539, 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity, is a key molecular function in the biosynthesis of prenylated phenols, with implications for cellular respiration, redox balance, and disease. Understanding its mechanism, regulation, and genetic control provides a foundation for therapeutic and biotechnological applications. CRISPR-based models offer powerful tools to dissect this activity in relevant biological contexts.
References
- 1. Schayer RW. 1974. Histamine and microcirculation.. Life Sci 15(3):391-401 PMID: 4620963
- 2. Buckel W. 2001. Sodium ion-translocating decarboxylases.. Biochim Biophys Acta 1505(1):15-27 PMID: 11248185
- 4. Ward OP et al.. 2000. Enzymatic asymmetric synthesis by decarboxylases.. Curr Opin Biotechnol 11(6):520-6 PMID: 11102784
- 5. Wu R et al.. 2022. Aconitate decarboxylase 1 is a mediator of polymicrobial sepsis.. Sci Transl Med 14(659):eabo2028 PMID: 36001682
- 6. Naseem M et al.. 2018. The Cytokinin-Activating LOG-Family Proteins Are Not Lysine Decarboxylases.. Trends Biochem Sci 43(4):232-236 PMID: 29525484
- 7. Bisello G et al.. 2020. Oxygen reactivity with pyridoxal 5'-phosphate enzymes: biochemical implications and functional relevance.. Amino Acids 52(8):1089-1105 PMID: 32844248
- 8. Okawa A et al.. 2021. Structural basis for substrate specificity of l-methionine decarboxylase.. Protein Sci 30(3):663-677 PMID: 33452696
